The current review supports our hypothesis that differences in incidence and severity of COVID-19 infection might be directly related to the degree of ACE2 expression, which could have meaningful implications for future directions in developing a global strategy to combat risks of severe infection and mortality. Here, ACE2 is linked to infection.